<html>
<head>
	<META HTTP-EQUIV="Pragma" CONTENT="no-cache">
	<META HTTP-EQUIV="Cache-Control" CONTENT="no-store">
	<title> Drug Patent Expirations Boost Antidepressant Markets to $14 Billion by 2006, Says Frost & Sullivan </title>
<!-- Hiding from old browsers -->
<SCRIPT LANGUAGE=JavaScript>
   function userButton(btnStr)
   {
      document.forms[0].theButton.value = btnStr;
      document.forms[0].submit();
   }
<!-- End Hiding from old browsers -->
</SCRIPT>
</head>

<body BGCOLOR="#FFFFFF">
<table border="0" cellspacing="0" cellpadding="0" width="468">
<TR><TD width="468">
<FONT FACE="verdana, arial, helvetica, san-serif" SIZE="+1">

<!-- Begin DoubleClick ad head --><NOLAYER><IFRAME SRC="http://ad.doubleclick.net/adi/np.newspage.com/Top+Pharmaceutical+Companies;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=top;sz=468x60;tile=1;ord=986547837273?" name="banner1" frameborder=0 marginheight=0 marginwidth=0 width=468 height=80 scrolling=no><A HREF="http://ad.doubleclick.net/jump/np.newspage.com/Top+Pharmaceutical+Companies;abr=!ie;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=top;sz=468x60;tile=1;ord=986547837273?" target="_top"><IMG BORDER="0" SRC="http://ad.doubleclick.net/ad/np.newspage.com/Top+Pharmaceutical+Companies;abr=!ie;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=top;sz=468x60;tile=1;ord=986547837273?"><BR>Click Here!</A></IFRAME></NOLAYER><ILAYER ID=banner1 VISIBILITY=HIDE HEIGHT=80 WIDTH=468></ILAYER><!-- End DoubleClick ad head -->

<br>
<br>
<B>Drug Patent Expirations Boost Antidepressant Markets to $14 Billion by 2006, Says Frost & Sullivan</B></FONT>
</td></tr>
<!--blue line -->
<TR>
<TD BGCOLOR="#003366"><IMG SRC="/images/util/dotclear.gif" HEIGHT="4" WIDTH="1"></TD>
</TR> 

<TR><TD width="468"> 
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" width="468">
    <TR>
	<!-- story area -->
    <TD VALIGN="top" width="468">
      <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" width="328">
        <TR><TD width="328"><IMG SRC="/images/util/dotclear.gif" WIDTH="1" HEIGHT="5"></TD></TR>
		<TR><TD width="328"><FONT FACE= "verdana, arial, helvetica, san-serif">
		<FONT SIZE="-1"> <B> April 6, 2001
 </B><br><br><input type="Hidden" NAME="theButton"><A HREF=JavaScript:userButton("Email_frames")><img src="/images/buttons/email_story_to_a_friend_b.gif" border="0"></A>&nbsp;<A HREF=JavaScript:userButton("Fax_frames")><img src="/images/buttons/fax_story_to_a_friend_b.gif" border="0"></A><BR> <HR SIZE="1" NOSHADE><P>
		
<!-- begin full-text -->
<EM>SAN JOSE, Calif.--(BW HealthWire)--April 5, 2001 via NewsEdge Corporation </EM> - <P>
A
not-so-depressing situation is developing for users of antidepressant
medications such as Prozac and Zoloft, however, the makers of these
drugs might have a different view.
</P>
<P>
The U.S. market will soon witness an introduction of generic
equivalents to these products, providing the impetus for tremendous
overall market growth and resulting in a range of low-cost
prescription options for patients.
</P>
<P>
Frost &amp; Sullivan's (http://healthcare.frost.com) latest strategic
health care analysis of the U.S. Antidepressant Medications Markets
projects revenues to top $14 billion by 2006, which more than doubles
the revenue estimates of 1999. Total revenues accounted for in Frost &amp;
Sullivan's research come from two segments: The markets for atypical
antidepressants, and the markets for selective serotonin reuptake
inhibitors (SSRI), respectively.
</P>
<P>
&quot;Any one of several trends may change the landscape of the U.S.
antidepressant medications market,&quot; says Frost &amp; Sullivan
Pharmaceutical Industry Analyst Joe Warzecha. &quot;The biggest trend, and
the one everyone is talking about, is the encroaching generic-ization
of the market.&quot;
</P>
<P>
Several products will be facing generic competition for the first
time as name-brand drugs lose their patent protection. This will
result in increased competition for the companies that designed the
original products, and will be a windfall for generic manufacturers
and the 21 million Americans suffering from depression.
</P>
<P>
&quot;A generic drug is almost always sold at a lower price than
branded products,&quot; says Warzecha. &quot;Because there is a lower-priced
option, customers and doctors may move towards using generics.&quot;
</P>
<P>
Companies that designed the branded drugs, such as Prozac and
Zoloft, may face more competition, but it does not necessarily mean
they will lose market share. A strong brand goes a long way to
preserving revenues and many doctors and patients have intense loyalty
to products that have served them well in the past.
</P>
<P>
&quot;When a generic drug enters the market, companies with branded
products may lower their prices in an attempt to keep costs
competitive, but the prices of these drugs probably won't drop much,&quot;
says Warzecha. &quot;Since many of the products have such a strong brand
image, customer may not believe that the generic is as effective as
the branded product.&quot;
</P>
<P>
Price has been a major concern for all drug manufacturers. Recent
negative media attention has generated bad publicity for
antidepressant medications. The lowering of prices may actually
benefit companies because not only would it result in more units sold,
but it should also draw positive media coverage.
</P>
<P>
Frost &amp; Sullivan presents the 2000 Marketing Engineering Awards to
companies that have worked hard to make a positive contribution to the
U.S. antidepressant medications industry. The Market Engineering
Leadership Award for the total antidepressants medication market, goes
to Eli Lilly. Forest Laboratories is given the Strategic Alliance
Innovation Award. Glaxo Wellcome receives the Market Engineering
Leadership Award for the atypical antidepressant market.
</P>
<P>
Frost &amp; Sullivan, which is headquartered in San Jose, Calif., is a
global leader in international strategic market consulting and
training. Frost &amp; Sullivan's industry experts monitor the
pharmaceutical industry for market trends, market measurements and
strategies. This ongoing analysis is included in the frost.com
Pharmaceuticals Monitor Service, which includes research on the
European Markets for Psychotropic Drugs and the US Alzheimer's Disease
Medications Markets. Executive summaries and interviews are available
to the press.
</P>
<P>
Along with publishing in-depth strategic market consulting
research, Frost &amp; Sullivan also provides custom consulting services to
a variety of national and international companies.
</P>
<P>
U.S. Antidepressant Medications Market
Research: No. 7458-52
Date: March 2001
</P>
<P>
</P>
<P>CONTACT: Frost &amp; Sullivan |              Nick Mariottini, Phone/Fax: 530/894-2136 | nmariottini@frost.com | http://www.frost.com</P>

<!-- end full-text -->

		<FORM METHOD="POST" ACTION="/servlet/EmailOrFax">
<INPUT TYPE="hidden" NAME="story" VALUE="b0405080.100">
<INPUT TYPE="hidden" NAME="level1" VALUE="">
<INPUT TYPE="hidden" NAME="level2" VALUE="">
<INPUT TYPE="hidden" NAME="level3" VALUE="552">
<INPUT TYPE="hidden" NAME="date" VALUE="20010406">
<P>

<P>
<b>Would you like to email or fax this story<br>to a friend?</b></font><br><br></td>
	</tr>
	<tr>
		<td>&nbsp;&nbsp;&nbsp;&nbsp;
<!-- Buttons for Email and Fax a Friend -->

<input type="Hidden" NAME="theButton"><A HREF=JavaScript:userButton("Email_frames")><img src="/images/buttons/email_story_to_a_friend_b.gif" border="0"></A>&nbsp;<A HREF=JavaScript:userButton("Fax_frames")><img src="/images/buttons/fax_story_to_a_friend_b.gif" border="0"></A><br>
	</td>
</tr>
</table></TD>
	<!-- right hand column...(2) 120x90 ad, related stories, quicksearch, etc-->
	<TD ALIGN="right" VALIGN="top">
		<TABLE BGCOLOR="#FBEFD1" WIDTH="140" CELLPADDING="8" CELLSPACING="0" BORDER="0">
			<TR><TD BGCOLOR="#345B8A" HEIGHT="20"><FONT FACE="Verdana, Arial, Helvetica, sans-serif" COLOR="#FFFFFF" SIZE="-1"><B>More Articles</B></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/story.shtml?story=p0405153.400&date=20010406&level3=552">Scientific Breakthrough in the Karo Bio and Abb...</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/story.shtml?story=p0405022.100&date=20010406&level3=552">AnorMED earns Phase III milestone payment from ...</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/story.shtml?story=p0405085.600&date=20010406&level3=552">Schering Laboratories and SKOLAR Announce Onlin...</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/story.shtml?story=b0405093.404&date=20010406&level3=552">UNIVEC and Merck Partner with Honduras to Eradi...</A></FONT></TD></TR>

		<!-- Header topic_ad_tile 1-->	
			<TR><TD>
				<!-- Begin DoubleClick ad head --><NOLAYER><IFRAME SRC="http://ad.doubleclick.net/adi/np.newspage.com/Top+Pharmaceutical+Companies;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=button1;sz=120x90;tile=2;ord=986547837273?" name="tile1" frameborder=0 marginheight=0 marginwidth=0 width=120 height=90 scrolling=no><A HREF="http://ad.doubleclick.net/jump/np.newspage.com/Top+Pharmaceutical+Companies;abr=!ie;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=button1;sz=120x90;tile=2;ord=986547837273?" target="_top"><IMG BORDER="0" SRC="http://ad.doubleclick.net/ad/np.newspage.com/Top+Pharmaceutical+Companies;abr=!ie;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=button1;sz=120x90;tile=2;ord=986547837273?"></A></IFRAME></NOLAYER><ILAYER ID=tile1 VISIBILITY=HIDE HEIGHT=90 WIDTH=120></ILAYER><!-- End DoubleClick ad head -->

			</TD></TR>
	<!-- Header topic_ad_tile 2-->					
	<TR><TD>
				<!-- Begin DoubleClick ad head --><NOLAYER><IFRAME SRC="http://ad.doubleclick.net/adi/np.newspage.com/Top+Pharmaceutical+Companies;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=button2;sz=120x90;tile=3;ord=986547837273?" name="tile2" frameborder=0 marginheight=0 marginwidth=0 width=120 height=90 scrolling=no><A HREF="http://ad.doubleclick.net/jump/np.newspage.com/Top+Pharmaceutical+Companies;abr=!ie;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=button2;sz=120x90;tile=3;ord=986547837273?" target="_top"><IMG BORDER="0" SRC="http://ad.doubleclick.net/ad/np.newspage.com/Top+Pharmaceutical+Companies;abr=!ie;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=button2;sz=120x90;tile=3;ord=986547837273?"></A></IFRAME></NOLAYER><ILAYER ID=tile2 VISIBILITY=HIDE HEIGHT=90 WIDTH=120></ILAYER><!-- End DoubleClick ad head -->

			</TD></TR>

			<TR><TD BGCOLOR="#345B8A" HEIGHT="20"><FONT FACE="Verdana, Arial, Helvetica, sans-serif" COLOR="#FFFFFF" SIZE="-1"><B>Article Found In</B></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=333&date=20010406">Psychiatry & Psychology</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=334&date=20010406">Central Nervous System Disorders</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=357&date=20010406">Pharmaceutical Manufacturing</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=540&date=20010406">Central Nervous System Drugs</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=551&date=20010406">U.S. Pharmaceutical Industry</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=552&date=20010406">Top Pharmaceutical Companies</A></FONT></TD></TR>
<TR><TD><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-1"><A HREF="/frames/topic.shtml?topic=1976&date=20010406">Eli Lilly</A></FONT></TD></TR>
 
			<TR>
      		<TD BGCOLOR="#345B8A" HEIGHT="20"><FONT FACE="verdana, arial, helvetica, san-serif" COLOR="#ffffff" SIZE="-1"><B>Quick Search</B></FONT></TD>
      		</TR>
      		<TR>
      		<TD ><FORM action="http://pf.individual.com/news_search.asp" METHOD=GET>
				<INPUT type="hidden" name="action" value="go">
				<INPUT type="hidden" name="start" value="1">
				<INPUT TYPE="TEXT" SIZE="13" VALUE="" NAME="text">
				<INPUT TYPE="Image" NAME="NewSearchSubmitBtn" SRC="/images/buttons/go_b.gif" alt="Submit" BORDER="0" WIDTH="22" HEIGHT="14" VSPACE="0" HSPACE="0">
				</FORM></TD>
      		</TR>
		</TABLE>
	</td>
	</tr>
</TABLE>

</td>
</tr>
		<tr><td><!-- Begin DoubleClick ad head --><NOLAYER><IFRAME SRC="http://ad.doubleclick.net/adi/np.newspage.com/Top+Pharmaceutical+Companies;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=bottom;sz=468x60;tile=4;ord=986547837273?" name="banner2" frameborder=0 marginheight=0 marginwidth=0 width=468 height=80 scrolling=no><A HREF="http://ad.doubleclick.net/jump/np.newspage.com/Top+Pharmaceutical+Companies;abr=!ie;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=bottom;sz=468x60;tile=4;ord=986547837273?" target="_top"><IMG BORDER="0" SRC="http://ad.doubleclick.net/ad/np.newspage.com/Top+Pharmaceutical+Companies;abr=!ie;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=bottom;sz=468x60;tile=4;ord=986547837273?"><BR>Click Here!</A></IFRAME></NOLAYER><ILAYER ID=banner2 VISIBILITY=HIDE HEIGHT=80 WIDTH=468></ILAYER><!-- End DoubleClick ad head -->
</td></tr>
	
<tr><td><br><IMG SRC="/images/logos/73x29.gif" WIDTH="73" HEIGHT="29"><FONT FACE="Verdana, Arial, Helvetica, sans-serif" SIZE="-2">&nbsp;&nbsp;<A HREF="/terms.shtml" TARGET="CONTENT"><B>Copyright &copy; 2001</B></A>, <A HREF="/about.shtml" TARGET="_top"><B>Individual.com, Inc.</A></B><font size="-5"><sup><font color="#0000CC">TM</font></sup></font>
</td></tr>
	
	</td>
</tr>
</table>

	
	<!-- Begin DoubleClick ad foot --><LAYER SRC="http://ad.doubleclick.net/adl/np.newspage.com/Top+Pharmaceutical+Companies;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=top;sz=468x60;tile=5;ord=986547837273?" visibility=hide onload="moveToAbsolute(banner1.pageX, banner1.pageY); clip.height=80; clip.width=468; visibility='show';"></LAYER><!-- End DoubleClick ad foot -->


	
	<!-- Begin DoubleClick ad foot --><LAYER SRC="http://ad.doubleclick.net/adl/np.newspage.com/Top+Pharmaceutical+Companies;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=button1;sz=120x90;tile=6;ord=986547837273?" visibility=hide onload="moveToAbsolute(tile1.pageX, tile1.pageY); clip.height=90; clip.width=120; visibility='show';"></LAYER><!-- End DoubleClick ad foot -->

					
		<!-- Begin DoubleClick ad foot --><LAYER SRC="http://ad.doubleclick.net/adl/np.newspage.com/Top+Pharmaceutical+Companies;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=button2;sz=120x90;tile=7;ord=986547837273?" visibility=hide onload="moveToAbsolute(tile2.pageX, tile2.pageY); clip.height=90; clip.width=120; visibility='show';"></LAYER><!-- End DoubleClick ad foot -->

			
	</SERVLET>
	<!-- Begin DoubleClick ad foot --><LAYER SRC="http://ad.doubleclick.net/adl/np.newspage.com/Top+Pharmaceutical+Companies;depid=552;indid=46610;!category=np_comp;u=b0405080_100;pos=bottom;sz=468x60;tile=8;ord=986547837273?" visibility=hide onload="moveToAbsolute(banner2.pageX, banner2.pageY); clip.height=80; clip.width=468; visibility='show';"></LAYER><!-- End DoubleClick ad foot -->



</body>
</html>
